SEARCH

SEARCH BY CITATION

References

  • 1
    Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective.International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995; 87: 796-802.
  • 2
    Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999; 189: 12-19.
  • 3
    Klussmann JP, Gultekin E, Weissenborn SJ, et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol. 2003; 162: 747-753.
  • 4
    Lu DW, El-Mofty SK, Wang HL. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA. Mod Pathol. 2003; 16: 692-699.
  • 5
    Rubin MA, Kleter B, Zhou M, et al. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol. 2001; 159: 1211-1218.
  • 6
    Santos M, Landolfi S, Olivella A, et al. p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas. Am J Surg Pathol. 2006; 30: 1347-1356.
  • 7
    D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007; 356: 1944-1956.
  • 8
    Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000; 92: 709-720.
  • 9
    Herrero R, Castellsague X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003; 95: 1772-1783.
  • 10
    Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008; 26: 612-619.
  • 11
    Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008; 100: 261-269.
  • 12
    Li W, Thompson CH, O'Brien CJ, et al. Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer. 2003; 106: 553-558.
  • 13
    Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer. 2001; 92: 805-813.
  • 14
    Kumar B, Cordell KG, Lee JS, et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol. 2008; 26: 3128-3137.
  • 15
    Worden FP, Kumar B, Lee JS, et al. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol. 2008; 26: 3138-3146.
  • 16
    Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine. 2006; 24( suppl 3): S11-S25.
  • 17
    National history and epidemiology of HPV infection. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol 90: Human papillomaviruses. Lyon International Agency for Research on Cancer. 2007: 68-92.
  • 18
    Syrjanen KJ. HPV infections in benign and malignant sinonasal lesions. J Clin Pathol. 2003; 56: 174-181.
  • 19
    Hoffmann M, Klose N, Gottschlich S, et al. Detection of human papillomavirus DNA in benign and malignant sinonasal neoplasms. Cancer Lett. 2006; 239: 64-70.
  • 20
    El-Mofty SK, Lu DW. Prevalence of high-risk human papillomavirus DNA in nonkeratinizing (cylindrical cell) carcinoma of the sinonasal tract: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2005; 29: 1367-1372.
  • 21
    GreeneFI, PageDL, FlemingID, et al, eds. AJCC Cancer Staging Manual.6th ed. Berlin, Germany: Springer; 2002.
  • 22
    Pilch BZ, Bouquot J, Thompson LDR. Squamous cell carcinoma of the nasal cavity and paranasal sinuses (sinonasal carcinoma). In: BarnesL, EvesonJW, ReichartP, SidranskyD, eds. World Health Organization Classification of Tumours. Head and Neck Tumours. Lyon, France: World Health Organization; 2004: 15-17.
  • 23
    Horn LC, Reichert A, Oster A, et al. Immunostaining for p16INK4a used as a conjunctive tool improves interobserver agreement of the histologic diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol. 2008; 32: 502-512.
  • 24
    Klaes R, Benner A, Friedrich T, et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol. 2002; 26: 1389-1399.
  • 25
    Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001; 94: 153-156.
  • 26
    Ayiomamitis A, Parker L, Havas T. The epidemiology of malignant neoplasms of the nasal cavities, the paranasal sinuses and the middle ear in Canada. Arch Otorhinolaryngol. 1988; 244: 367-371.
  • 27
    Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer. 2001; 92: 3012-3029.
  • 28
    Muir CS, Nectoux J. Descriptive epidemiology of malignant neoplasms of nose, nasal cavities, middle ear and accessory sinuses. Clin Otolaryngol Allied Sci. 1980; 5: 195-211.
    Direct Link:
  • 29
    Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988; 48: 3282-3287.
  • 30
    El-Mofty SK, Lu DW. Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2003; 27: 1463-1470.
  • 31
    Sidransky D. Molecular genetics of head and neck cancer. Curr Opin Oncol. 1995; 7: 229-233.
  • 32
    Todd R, Donoff RB, Wong DT. The molecular biology of oral carcinogenesis: toward a tumor progression model. J Oral Maxillofac Surg. 1997; 55: 613-623.
  • 33
    Hafkamp HC, Speel EJ, Haesevoets A, et al. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Int J Cancer. 2003; 107: 394-400.
  • 34
    Scholes AG, Liloglou T, Snijders PJ, et al. p53 mutations in relation to human papillomavirus type 16 infection in squamous cell carcinomas of the head and neck. Int J Cancer. 1997; 71: 796-799.
  • 35
    van Houten V, Snijders PJ, van den Brekel MW, et al. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer. 2001; 93: 232-235.
  • 36
    Buchwald C, Lindeberg H, Pedersen BL, Franzmann MB. Human papilloma virus and p53 expression in carcinomas associated with sinonasal papillomas: a Danish Epidemiological study 1980-1998. Laryngoscope. 2001; 111: 1104-1110.
  • 37
    Shen J, Tate JE, Crum CP, Goodman ML. Prevalence of human papillomaviruses (HPV) in benign and malignant tumors of the upper respiratory tract. Mod Pathol. 1996; 9: 15-20.
  • 38
    Bernauer HS, Welkoborsky HJ, Tilling A, Amedee RG, Mann WJ. Inverted papillomas of the paranasal sinuses and the nasal cavity: DNA indices and HPV infection. Am J Rhinol. 1997; 11: 155-160.
  • 39
    Weber RS, Shillitoe EJ, Robbins KT, et al. Prevalence of human papillomavirus in inverted nasal papillomas. Arch Otolaryngol Head Neck Surg. 1988; 114: 23-26.
  • 40
    Syrjanen K, Syrjanen S. Papillomavirus Infections in Human Disease. New York, NY: Wiley; 2000: 1-615.